P. Thuluvath

发表

Retransplantation of liver: Primary graft nonfunction and hepatitis C virus are associated with worse outcome

H. Yoo, Anurag Maheshwari, P. Thuluvath, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.

R. Marinho, J. Dufour, P. Thuluvath, 2018, Journal of hepatology.

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

J. Bruix, J. Llovet, A. Zhu, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful closure of a chronic refractory gastrocutaneous fistula with a new endoscopic suturing device (with video).

S. Kantsevoy, P. Thuluvath, 2012, Gastrointestinal endoscopy.

All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study

P. Thuluvath, K. Kowdley, D. Bernstein, 2015, Hepatology.

The Impact of Cirrhosis and Portal Hypertension on Mortality Following Colorectal Surgery: A Nationwide, Population-Based Study

P. Thuluvath, G. Nguyen, A. Correia, 2009, Diseases of the colon and rectum.

Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

P. Thuluvath, G. Nguyen, F. Millwala, 2007, World journal of gastroenterology.

Percutaneous loco-regional therapy of unresectable hepatocellular carcinoma (HCC) with cisplatin/epinephrine (CDDP/EPI) injectable gel

G. Gores, T. Vogl, P. Thuluvath, 2001 .

Randomised , double blind , placebo controlled trial of interferon , ribavirin , and amantadine versus interferon , ribavirin , and placebo in treatment naı̈ve patients with chronic hepatitis

P. Thuluvath, F. Anania, M. Ryan, 2003 .

Effect Modification in Liver Allografts With Prolonged Cold Ischemic Time

L. Kucirka, P. Thuluvath, D. Segev, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Outcomes of status 1 liver transplantation for Budd‐Chiari Syndrome with fulminant hepatic failure

P. Thuluvath, Talan Zhang, Joseph Alukal, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Karnofsky performance status before and after liver transplantation predicts graft and patient survival.

P. Thuluvath, A. Thuluvath, Y. Savva, 2018, Journal of hepatology.

Outcomes of liver transplantation for glycogen storage disease: a matched‐control study and a review of literature

Anurag Maheshwari, P. Thuluvath, D. Segev, 2012, Clinical transplantation.

Outcome of liver transplantation in patients with diabetes mellitus: A case‐control study

P. Thuluvath, P. John, 2001 .

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

O. Weiland, P. Thuluvath, G. Everson, 2014, Gut.

Independent risk factors and natural history of renal dysfunction in liver transplant recipients

D. Fine, P. Thuluvath, A. Pawarode, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Are Gastrointestinal Symptoms Specific for Coronavirus 2019 Infection? A Prospective Case-Control Study From the United States

P. Thuluvath, Talan Zhang, Alan Chen, 2020, Gastroenterology.

The V599E BRAF mutation is uncommon in biliary tract cancers

P. Argani, A. Maitra, I. Wistuba, 2004, Modern Pathology.

Disease recurrence after liver transplantation : natural history, treatment and survival

P. Thuluvath, 2016 .

1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

A. Lok, K. Reddy, P. Thuluvath, 2012 .

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

P. Marcellin, P. Thuluvath, G. Everson, 2014, Gastroenterology.

REPLY:

P. Thuluvath, S. Satapathy, A. Kovalic, 2021 .

Mycophenolate mofetil monotherapy in liver transplant recipients: A single center experience

P. Thuluvath, K. Fairbanks, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

When is diabetes mellitus a relative or absolute contraindication to liver transplantation?

P. Thuluvath, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Cryptogenic Cirrhosis and NAFLD: Are They Related?

Anurag Maheshwari, P. Thuluvath, 2006, The American Journal of Gastroenterology.

Mortality from hepatocellular and biliary cancers: changing epidemiological trends

P. Thuluvath, K. Shivakumar, S. Nair, 2002, American Journal of Gastroenterology.

OriginalClinicalScienceçLiver Liver Transplantation in Cryptogenic Cirrhosis : Outcome Comparisons Between NASH , Alcoholic , and AIH Cirrhosis

P. Thuluvath, S. Hanish, Y. Savva, 2018 .

Is cryptogenic cirrhosis different from NASH cirrhosis?

S. Kantsevoy, P. Thuluvath, A. Thuluvath, 2017, Journal of hepatology.

Prevalence of Transaminase Abnormalities in Asymptomatic, Healthy Subjects Participating in an Executive Health-Screening Program

H. Yoo, P. Thuluvath, J. Flynn, 2003, Digestive Diseases and Sciences.

Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.

G. Gores, K. Engelmann, T. Vogl, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of the Efficacy and Safety of Cisplat in-Epinephrine Injectable Gel Adminis tered to Pat ients With Unresectable

G. Gores, K. Engelmann, T. Vogl, 2003 .

Chemoembolization of hepatocellular carcinoma: results of a metaanalysis.

M. Choti, P. Thuluvath, J. Geschwind, 2003, American journal of clinical oncology.

Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID‐19: Systematic Review and Meta‐analysis

P. Thuluvath, S. Satapathy, A. Kovalic, 2020, Hepatology.

Purely endoscopic appendectomy

S. Kantsevoy, P. Thuluvath, A. Raina, 2022, VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy.

Endoscopic en bloc removal of appendiceal polyp facilitated by traction

S. Kantsevoy, P. Thuluvath, A. Raina, 2019, VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy.

Impact of Chronic Kidney Disease on Outcomes in Cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.

A. Lok, K. Reddy, T. Hassanein, 2014, The New England journal of medicine.

Effect of Sofosbuvir/Ledipasvir and Glecaprevir/Pibrentasvir on Serum Creatinine.

Anurag Maheshwari, P. Thuluvath, Waseem Amjad, 2021, Journal of clinical and experimental hepatology.

Liver ultrasound in cirrhosis is inadequate for hepatocellular carcinoma surveillance compared to magnetic resonance imaging

P. Thuluvath, Amol Agarwal, Nishal Ravindran, 2022, Liver Cancer International.

Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.

L. Lawler, S. Kantsevoy, I. Kamel, 2005, Gastrointestinal endoscopy.

Survival after liver transplantation for hepatocellular carcinoma in the model for end‐stage liver disease and pre–model for end‐stage liver disease eras and the independent impact of hepatitis C virus

Anurag Maheshwari, P. Thuluvath, D. Segev, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.

Anurag Maheshwari, P. Thuluvath, J. Price, 2016, Journal of clinical and experimental hepatology.

Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.

P. Thuluvath, I. Doycheva, 2020, Translational gastroenterology and hepatology.

Universal HCV Screening of Baby Boomers is Feasible, but It is Difficult

P. Thuluvath, Talan Zhang, Joseph Alukal, 2021, Journal of Clinical and Experimental Hepatology.

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.

P. Thuluvath, V. Luketic, N. Pyrsopoulos, 2016, Annals of hepatology.

Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens

G. Gerken, K. Chayama, K. Reddy, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease

Anurag Maheshwari, P. Thuluvath, Waseem Amjad, 2020, Digestive Diseases and Sciences.

Treatment of Recurrent Hepatitis C

P. Thuluvath, Anantha K. Nuthalapati, 2016 .

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.

P. Thuluvath, T. Pilot‐Matias, U. Akarca, 2015, Gastroenterology.

Randomized Study of Asunaprevir plus Pegylated Interferon-α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C

K. Reddy, P. Thuluvath, S. Pol, 2013, Antiviral therapy.

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1‐infected treatment‐naive patients

T. Hassanein, P. Thuluvath, G. Everson, 2016, Liver international : official journal of the International Association for the Study of the Liver.

A randomized, placebo‐controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1

P. Thuluvath, E. Lawitz, R. Ghalib, 2015, Journal of viral hepatitis.

Outcome of liver transplantation in adult recipients: Influence of neighborhood income, education, and insurance

H. Yoo, P. Thuluvath, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Complementary and alternative medicine in hepatology: review of the evidence of efficacy.

P. Thuluvath, S. Verma, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION

T. Hassanein, P. Thuluvath, L. Webster, 2014 .

N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies

W. Qureshi, P. Thuluvath, Waseem Amjad, 2021, Przeglad gastroenterologiczny.

Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.

M. Choti, M. Torbenson, P. Thuluvath, 2006, Human pathology.

Esophageal capsule endoscopy is not the optimal technique to determine the need for primary prophylaxis in patients with cirrhosis

S. Kantsevoy, P. Thuluvath, K. Krok, 2016, Archives of medical science : AMS.

Role of endoscopy for primary prophylaxis of variceal bleeding

S. Kantsevoy, P. Thuluvath, 2005 .

Primary prophylaxis of variceal bleeding.

P. Thuluvath, A. Krishnan, 2003, Gastrointestinal endoscopy.

Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: A clinical and electrophysiologic study

P. Thuluvath, D. Cornblath, A. Corse, 1999, Hepatology.

Selenium in chronic liver disease.

P. Thuluvath, D. Triger, 1992, Journal of hepatology.

Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time?

P. Thuluvath, K. Krok, 2005, The American Journal of Gastroenterology.

Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study

R. Groszmann, D. Ganger, N. Chalasani, 2017, Journal of clinical gastroenterology.

Assessment of nutritional status via anthropometry.

P. Thuluvath, L. R. Shiveley, 1997, Nutrition.

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.

P. Thuluvath, M. Kipnes, M. Abdelmalek, 2022, The lancet. Gastroenterology & hepatology.

Claudin-1 and its potential role in HCV entry: another piece of the puzzle.

P. Thuluvath, J. Hamilton, 2008, Journal of clinical gastroenterology.

Endoscopic management of biliary complications after liver transplantation.

P. Thuluvath, A. Cárdenas, K. Krok, 2010, Clinics in liver disease.

An endoscopic approach to biliary complications following orthotopic liver transplantation

P. Thuluvath, T. Atassi, John Lee, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.

K. Reddy, P. Kamath, P. Thuluvath, 2019, The American journal of gastroenterology.

Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.

P. Thuluvath, Waseem Amjad, Talan Zhang, 2020, Journal of clinical and experimental hepatology.

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol

B. Winters, P. Thuluvath, R. Montgomery, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Intrabiliary MR imaging: assessment of biliary obstruction with use of an intraluminal MR receiver coil.

Clifford R Weiss, David A Bluemke, Michael Choti, 2006, Journal of vascular and interventional radiology : JVIR.

Hilar cholangiocarcinoma: staging with intrabiliary MRI.

M. Choti, D. Bluemke, L. Hofmann, 2004, AJR. American journal of roentgenology.

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus

D. Fine, P. Thuluvath, J. Eustace, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Does race-matched liver transplantation offer any graft survival benefit?

P. Thuluvath, S. Nair, 2001, Transplantation proceedings.

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

M. Choti, I. Kamel, C. Georgiades, 2005, Journal of vascular and interventional radiology : JVIR.

Toward safer sedation in patients with cirrhosis: have we done enough?

P. Thuluvath, 2009, Gastrointestinal endoscopy.

Hyponatremia in Cirrhosis: An Update.

P. Thuluvath, S. John, Joseph Alukal, 2020, The American journal of gastroenterology.

Post‐liver‐transplant anemia: Etiology and management

Anurag Maheshwari, P. Thuluvath, Rajnish Mishra, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

K. Reddy, P. Kamath, P. Thuluvath, 2017, The American Journal of Gastroenterology.

Endoscopic retrograde cholangiography for biliary anastomotic strictures after liver transplantation.

P. Thuluvath, A. Cárdenas, Á. Díaz‐González, 2014, Clinics in liver disease.

Renal Insufficiency May Partly Explain Chronic Anemia in Patients Awaiting Liver Transplantation

P. Thuluvath, K. Fairbanks, C. Patt, 2004, Digestive Diseases and Sciences.

Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.

Krishnakant V. Saboo, Chang Hu, K. Reddy, 2020, The American journal of gastroenterology.

Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort

K. Reddy, P. Kamath, P. Thuluvath, 2019, Alimentary pharmacology & therapeutics.

Outcomes After Listing for Liver Transplant in Patients With Acute‐on‐Chronic Liver Failure: The Multicenter North American Consortium for the Study of End‐Stage Liver Disease Experience

K. Reddy, P. Kamath, P. Thuluvath, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

K. Reddy, P. Kamath, P. Thuluvath, 2019, The American journal of gastroenterology.

Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort

K. Reddy, P. Kamath, P. Thuluvath, 2017, The American Journal of Gastroenterology.

Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures

P. Kamath, P. Thuluvath, S. Biggins, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Chronic Pancreatitis: Long-Term Pain Relief With or Without Surgery, Cancer Risk, and Mortality

J. Cameron, P. Thuluvath, S. Nair, 2003, Journal of clinical gastroenterology.

Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis

Anurag Maheshwari, P. Thuluvath, K. Krok, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Gastrointestinal Failure in Critically Ill Patients With Cirrhosis.

P. Thuluvath, Joseph Alukal, J. Alukal, 2019, The American journal of gastroenterology.

Evaluation of nutritional status by using anthropometry in adults with alcoholic and nonalcoholic liver disease.

P. Thuluvath, D. Triger, 1994, The American journal of clinical nutrition.

Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C

P. Thuluvath, F. Anania, M. Ryan, 2003, Gut.

Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin

P. Thuluvath, J. Maygers, H. Pande, 2003, Digestive Diseases and Sciences.

Spontaneous bacterial peritonitis—in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998

Richard E Thompson, P. Thuluvath, S. Morss, 2001, American Journal of Gastroenterology.

Liver failure as initial presentation of autoimmune hepatitis: Clinical characteristics, predictors of response to steroid therapy, and outcomes

Anurag Maheshwari, P. Thuluvath, S. Verma, 2009, Hepatology.

Accuracy and Inter-observer Agreement Among Endoscopists for Visual Identification of Colorectal Polyps Using Endoscopy Images

S. Kantsevoy, Anurag Maheshwari, P. Thuluvath, 2022, Digestive Diseases and Sciences.

Liver transplantation in patients with acute-on-chronic liver failure

P. Thuluvath, Joseph Alukal, G. Lanke, 2022, Hepatology International.

A model to predict inhospital mortality in patients with cirrhosis, ascites and hyponatremia

P. Thuluvath, Talan Zhang, Joseph Alukal, 2022, European journal of gastroenterology & hepatology.

Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation

P. Thuluvath, W. Maley, D. B. Cohen, 2001, American Journal of Gastroenterology.

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts

Aaron M. Winnick, P. Thuluvath, T. Schiano, 2022, Euroasian Journal of Hepato-Gastroenterology.

GP73 and Liver Disease: A (Golgi) Complex Enigma

A. Maitra, P. Thuluvath, 2004, American Journal of Gastroenterology.

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.

J. Chan, D. Rockey, P. Thuluvath, 2020, Journal of hepatology.

Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension.

J. Chan, P. Thuluvath, J. Bosch, 2019, Journal of hepatology.

LBO-01-Multicenter, double-blind, placebo-controlled, randomized trial of emricasan in subjects with NASH cirrhosis and severe portal hypertension

J. Chan, P. Thuluvath, J. Bosch, 2019, Journal of Hepatology.

How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?

H. Yoo, Anurag Maheshwari, P. Thuluvath, 2020, Digestive Diseases and Sciences.

Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

P. Thuluvath, H. Pande, 2012, Drugs.

Autonomic Dysfunction and Cholelithiasis in Patients with Cirrhosis

A. Chawla, P. Thuluvath, L. Puthumana, 2001, Digestive Diseases and Sciences.

Autonomic neuropathy and chronic liver disease.

P. Thuluvath, D. Triger, 1989, The Quarterly journal of medicine.

Spontaneous bacterial peritonitis - In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998

Richard E Thompson, P. Thuluvath, S. Morss, 2001 .

Diarrhea in liver transplant recipients: Etiology and management

P. Thuluvath, P. Ginsburg, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics

H. Yoo, Anurag Maheshwari, P. Thuluvath, 2019, Medicine.

Hepatorenal syndrome.

P. Thuluvath, S. Turban, M. Atta, 2007, World journal of gastroenterology.

Impact of Hyponatremia on Morbidity, Mortality, and Resource Utilization in Portal Hypertensive Ascites: A Nationwide Analysis.

P. Thuluvath, Talan Zhang, Joseph Alukal, 2021, Journal of clinical and experimental hepatology.

Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2022, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Outcome of patients with new‐onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus

P. Thuluvath, P. John, Preeti R John, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Endoscopic retrograde cholangiopancreatography, but not esophagogastroduodenoscopy or colonoscopy, significantly increases portal venous pressure: direct portal pressure measurements through endoscopic ultrasound-guided cannulation.

S. Giday, S. Kantsevoy, P. Thuluvath, 2008, Endoscopy.

Biliary complications and outcomes of liver transplantation from donors after cardiac death

Anurag Maheshwari, P. Thuluvath, W. Maley, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Accuracy and reliability of the endoscopic classification of portal hypertensive gastropathy.

S. Kantsevoy, A. Kalloo, H. Yoo, 2002, Gastrointestinal endoscopy.

Outcome of Orthotopic Liver Transplantation in Patients with Hepatitis C

P. Thuluvath, J. Boitnott, S. Paik, 2002, Digestive Diseases and Sciences.

1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

P. Thuluvath, S. Pol, D. Larrey, 2012 .

1373 FIRST REPORT OF SVR12 FOR A NS5A REPLICATION COMPLEX INHIBITOR BMS-790052 IN COMBINATION WITH PEG-IFNa-2A AND RBV: PHASE 2A TRIAL IN TREATMENT-NAIVE HCV-GENOTYPE-1 SUBJECTS

P. Thuluvath, G. Everson, S. Pol, 2011 .

Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.

P. Thuluvath, P. John, 2001, Hepatology.

Acute hepatitis C

S. Ray, Anurag Maheshwari, P. Thuluvath, 2008, The Lancet.

Systematic review with meta‐analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis

P. Thuluvath, S. Satapathy, A. Kovalic, 2020, Alimentary pharmacology & therapeutics.

Recurrence of Hepatocellular Carcinoma Following Liver Transplantation Within Milan Criteria

P. Thuluvath, S. Hanish, Anantha K. Nuthalapati, 2016 .

Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials

P. Thuluvath, D. Segev, R. Montgomery, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Risk of Colorectal Adenoma in Liver Transplant Recipients Compared to Immunocompetent Control Population Undergoing Routine Screening Colonoscopy

P. Thuluvath, T. Atassi, 2003, Journal of clinical gastroenterology.

Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial

J. Cofer, P. Thuluvath, T. Pruett, 1996 .

Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2021, Hepatology.

If Hoofbeats are not From Horses, It Could be Zebras!! Isolated Hyper-alkaline Phosphatasemia.

P. Thuluvath, D. Alpers, J. Hamilton, 2020, Journal of clinical and experimental hepatology.

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection

P. Thuluvath, R. Chung, G. Everson, 2015, Annals of Internal Medicine.

Efficacy, safety, and tolerability in patients switched to PEG (40 kDa) IFN α-2a (PEGASYS®) after discontinuation from interferon alfa-2b plus ribavirin (REBETRON™) combination therapy for chronic hepatitis C

P. Thuluvath, P. Pockros, K. Rothstein, 2001 .

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.

J. Geschwind, H. Yoo, P. Thuluvath, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased signals seen in globus pallidus in T1‐weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy

P. Thuluvath, D. Edwin, N. C. Yue, 1995, Hepatology.

Intussusception of the appendix due to endometriosis.

H. Pitt, P. Thuluvath, E. Wallach, 1995, The American journal of gastroenterology.

Overview: Disease Recurrence After Liver Transplantation

P. Thuluvath, 2016 .

Effect of race on outcome of orthotopic liver transplantation: a cohort study

P. Thuluvath, J. Eustace, S. Nair, 2002, The Lancet.

Trends in post–liver transplant survival in patients with hepatitis C between 1991 and 2001 in the united states

H. Yoo, P. Thuluvath, D. Segev, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation

H. Yoo, P. Thuluvath, Hwan Y Yoo, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Gender and ethnic differences in the post-liver transplant outcomes of patients with autoimmune hepatitis with acute liver failure at initial presentation: a case-control study

P. Thuluvath, S. Verma, Rebecca Rankin Wagennar, 2015, Archives of medical science : AMS.

Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients

P. Thuluvath, D. Edwin, A. Klein, 1999, Hepatology.

Vaccination in Chronic Liver Disease: An Update

P. Thuluvath, H. Naqvi, Joseph Alukal, 2021, Journal of Clinical and Experimental Hepatology.

Correlation between hepatitis B virus DNA levels and liver histology: is the controversy because of paucity of data?

P. Thuluvath, S. Verma, 2007, Journal of clinical gastroenterology.

Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: A nationwide analysis

Justina J. Sam, P. Thuluvath, G. Nguyen, 2008, Hepatology.

Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C.

P. Thuluvath, S. Pol, V. Ratziu, 2014, Journal of hepatology.

Liver Transplantation in the United States, 1999–2008

J J Fung, P. Thuluvath, M. Guidinger, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Management of acute hepatitis C.

Anurag Maheshwari, P. Thuluvath, Anurag Maheshwari, 2010, Clinics in liver disease.

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

P. Thuluvath, Mahak Chauhan, P. Robarts, 2021, Journal of Hepatology.

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

P. Thuluvath, S. Satapathy, A. Kovalic, 2020, Hepatology International.

Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab.

P. Thuluvath, M. Morris, Ankur Gupta, 2020, Journal of clinical and experimental hepatology.

Higher Prevalence and Severity of Hepatic Encephalopathy in Patients with HCV Cirrhosis and Diabetes Mellitus: Is Presence of Autonomic Neuropathy the Missing Part of the Puzzle?

P. Thuluvath, 2006, The American Journal of Gastroenterology.

Gastrointestinal Manifestations of COVID-19

P. Thuluvath, Joseph Alukal, J. Alukal, 2021 .

MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3

G. Gores, R. Hruban, A. Maitra, 2009, Hepatology.

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension.

H. Conjeevaram, N. Chalasani, D. Rockey, 2019, Gastroenterology.

Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma

Troels Z. Kristiansen, S. Iacobelli, P. Argani, 2004, Cancer.

Biliary Complications after Liver Transplantation: the Role of Endoscopy

G. Ginsberg, M. Kimmey, P. Pfau, 2005, Endoscopy.

What GI Physicians Need to Know During COVID-19 Pandemic

P. Thuluvath, S. Satapathy, Joseph Alukal, 2020, Digestive Diseases and Sciences.

Liver transplantation for primary sclerosing cholangitis: screening for biliary malignancy and the role of preemptive transplantation

P. Thuluvath, C. Patt, Cary H. Patt, 2002 .

Vascular invasion is the most important predictor of survival in HCC, but how do we find it?

P. Thuluvath, 2009, Journal of clinical gastroenterology.

Twenty years of liver transplantation for Budd‐Chiari syndrome: A national registry analysis

P. Thuluvath, D. Segev, R. Montgomery, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

An Introduction to Liver Disease in India

M. Rela, P. Thuluvath, A. Saraya, 2021, Clinical Liver Disease.

Endoscopic suturing closure of large mucosal defects after endoscopic submucosal dissection is technically feasible, fast, and eliminates the need for hospitalization (with videos).

Sergey V Kantsevoy, S. Kantsevoy, P. Thuluvath, 2014, Gastrointestinal endoscopy.

Torulopsis glabrata fungemia as a complication of a clotted transjugular intrahepatic portosystemic shunt.

P. Thuluvath, W. Mergner, P. Darwin, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Metabolic basis for high paracetamol dosage without hepatic injury: a case study

J. Tredger, P. Thuluvath, I. Murray-Lyon, 1995, Human & experimental toxicology.

Heart Rate Variability as a Predictor of Autonomic Dysfunction in Patients Awaiting Liver Transplantation

L. Fleisher, P. Thuluvath, S. Frank, 2000, Digestive Diseases and Sciences.

Natural history of autonomic neuropathy in chronic liver disease

P. Thuluvath, D. Triger, M. Hendrickse, 1992, The Lancet.

Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease

P. Thuluvath, S. Frank, J. Fleckenstein, 1996, Hepatology.

Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation

P. Thuluvath, J. Bal, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Successful removal of the proximally migrated pancreatic winged stent by using the SpyGlass visualization system.

S. Kantsevoy, P. Thuluvath, Evgeniya A Frolova, 2010, Gastrointestinal endoscopy.

Treatment of high-risk patients with symptomatic cholelithiasis by endoscopic gallbladder stenting.

P. Pasricha, A. Kalloo, P. Thuluvath, 1994, Gastrointestinal endoscopy.

A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video).

S. Giday, S. Kantsevoy, P. Thuluvath, 2009, Gastrointestinal endoscopy.

Lymphadenopathy, elevated liver function tests and weight loss in a 68‐year‐old man

P. Thuluvath, K. Krok, Micheal S Torbenson, 2007, Journal of digestive diseases.

Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis

P. Thuluvath, S. Hanish, Y. Savva, 2019, Transplantation.

Minimizing risk associated with elderly liver donors by matching to preferred recipients

P. Thuluvath, D. Segev, R. Montgomery, 2007, Hepatology.

Relationship of the Model for End-Stage Liver Disease (MELD) Scale to Hepatic Encephalopathy, as Defined by Electroencephalography and Neuropsychometric Testing, and Ascites

H. Yoo, P. Thuluvath, D. Edwin, 2003, American Journal of Gastroenterology.

Patients with Autonomic Neuropathy Are More Likely to Develop Hepatic Encephalopathy

Anurag Maheshwari, P. Thuluvath, Anil Thomas, 2004, Digestive Diseases and Sciences.

Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis.

P. Thuluvath, V. Chaudhry, L. Puthumana, 2001, Journal of hepatology.

Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation?

P. Thuluvath, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Association between hepatitis C, diabetes mellitus, and race. a case-control study.

P. Thuluvath, P. John, Preeti R John, 2003 .

Association Between Hepatitis C, Diabetes Mellitus, and Race: A Case-Control Study

P. Thuluvath, P. John, Preeti R John, 2003, American Journal of Gastroenterology.

Abdominal pain in HIV infection.

A. Forbes, B. Gazzard, P. Thuluvath, 1991, The Quarterly journal of medicine.

Identification of novel cellular targets in biliary tract cancers using global gene expression technology.

K. Lillemoe, P. Argani, A. Maitra, 2003, The American journal of pathology.

Small bowel infarction mimicking Crohn's ileitis

P. Thuluvath, J. Wiggins, M. Fehér, 1991, Postgraduate medical journal.

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.

T. Hassanein, P. Thuluvath, L. Webster, 2015, Journal of hepatology.

Portal hypertensive gastropathy

H. Yoo, P. Thuluvath, 2002, American Journal of Gastroenterology.

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study

P. Thuluvath, S. Nair, A. Poonawala, 2000, Hepatology.

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Ulysses Diva, Vinod K Rustgi, P. Thuluvath, 2012, The Lancet. Infectious diseases.

Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.

J. Eshleman, P. Argani, A. Maitra, 2009, The Journal of molecular diagnostics : JMD.

Utility of Bile Duct Brushings for the Early Detection of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis

A. Maitra, A. Pandey, D. Clark, 2006, Journal of clinical gastroenterology.

Screening for hepatocellular carcinoma.

P. Thuluvath, A. Koteish, Ayman A. Koteish, 2002, Journal of vascular and interventional radiology : JVIR.

A Proteomic Analysis of Human Bile*

Troels Z. Kristiansen, P. Argani, A. Maitra, 2004, Molecular & Cellular Proteomics.

The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2016, Hepatology.

1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN (RBV)-FREE REGIMEN OF DACLATASVIR (DCV), ASUNAPREVIR (ASV), AND BMS-791325 IN TREATMENT-NAIVE, HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS

P. Marcellin, P. Thuluvath, G. Everson, 2013 .

Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis.

P. Thuluvath, N. Schluterman, Deborah Greenberg, 2017, Journal of clinical and experimental hepatology.

A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Akhilesh Pandey, Marjan Gucek, Raghothama Chaerkady, 2008, Journal of proteome research.

Long-Term Outcome of Liver Transplantation in Patients With PSC: A Comparative Analysis With PBC

H. Yoo, Anurag Maheshwari, P. Thuluvath, 2004, American Journal of Gastroenterology.

The impact of ethnicity on the natural history of autoimmune hepatitis

M. Torbenson, P. Thuluvath, S. Verma, 2007, Hepatology.

Autonomic neuropathy may be associated with delayed orocaecal transit time in patients with cirrhosis

Anurag Maheshwari, P. Thuluvath, 2005, Autonomic Neuroscience.

Reply to Morton.

P. Thuluvath, Joseph Alukal, 2020, The American journal of gastroenterology.

Endocrine diseases and the liver.

Anurag Maheshwari, P. Thuluvath, 2011, Clinics in liver disease.

Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: A national study

P. Thuluvath, D. Segev, G. Nguyen, 2007, Hepatology.

Hospital experience and outcomes for esophageal variceal bleeding.

E. Bass, P. Thuluvath, S. Dy, 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.

P. Thuluvath, D. Segev, G. Nguyen, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

TIPS for Management of Refractory Ascites: Response and Survival Are Both Unpredictable

S. Mitchell, P. Thuluvath, A. Venbrux, 2003, Digestive Diseases and Sciences.

Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3

P. Thuluvath, R. Satoskar, C. To, 2021, Digestive Diseases and Sciences.

A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics

H. Yoo, P. Thuluvath, Paul J. Thuluvath, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax

P. Kamath, P. Thuluvath, S. Biggins, 2020, Digestive Diseases and Sciences.

Morbid obesity and gross malnutrition are both poor predictors of outcomes after liver transplantation: What can we do about it?

P. Thuluvath, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation

P. Thuluvath, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.

P. Thuluvath, I. Doycheva, 2019, Journal of clinical and experimental hepatology.

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)

A. Lok, K. Reddy, T. Hassanein, 2013 .

Racial disparity in liver disease: Biological, cultural, or socioeconomic factors

P. Thuluvath, G. Nguyen, 2008, Hepatology.

Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far

P. Thuluvath, S. Satapathy, P. Bharali, 2020, World journal of hepatology.

Gastrointestinal and Liver Manifestations of COVID-19

P. Thuluvath, Alan Chen, C. To, 2020, Annals of the National Academy of Medical Sciences (India).

Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

Susan Hutfless, Clifford R Weiss, Rachel Karchin, 2014, Hepatology.

Endoscopic ultrasound and fine needle aspiration for the diagnosis of hepatocellular carcinoma.

S. Kantsevoy, S. Jagannath, P. Thuluvath, 2008, Minerva gastroenterologica e dietologica.

18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma

A. Pandey, Min-Sik Kim, R. Chaerkady, 2008, Clinical Proteomics.

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases

P. Thuluvath, Mahak Chauhan, Feng Li, 2022, Annals of hepatology.

A vasopressin receptor antagonist (VPA‐985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo‐controlled trial

P. Thuluvath, L. Blendis, F. Wong, 2003, Hepatology.

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

V. Wong, P. Thuluvath, R. Maiwall, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States

P. Thuluvath, S. Verma, S. Nair, 2002, Hepatology.

Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect

P. Thuluvath, M. Bhaskaran, S. Satapathy, 2021, World journal of gastroenterology.

Bariatric Surgery in NAFLD

P. Thuluvath, Mahak Chauhan, Kuldeep Singh, 2022, Digestive Diseases and Sciences.

Reversal of NASH fibrosis with pharmacotherapy

P. Thuluvath, Joseph Alukal, J. Alukal, 2019, Hepatology International.

Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma

P. Thuluvath, D. Segev, G. Nguyen, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.

P. Thuluvath, C. Mcwherter, C. Berg, 2022, Journal of hepatology.

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

W. Kim, J. Dranoff, A. Lok, 2022, Digestive Diseases and Sciences.

Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study

S. Bergheanu, T. Hassanein, B. Bacon, 2020, Journal of Hepatology.

Caroli's disease and outcomes after liver transplantation

P. Thuluvath, D. Segev, F. Millwala, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

P. Thuluvath, S. Verma, S. Nair, 2002, Hepatology.

A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection.

P. Thuluvath, J. Fleckenstein, M. Paredes, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis.

P. Thuluvath, G. Nguyen, E. Ahn, 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics

P. Thuluvath, Waseem Amjad, Talan Zhang, 2020, PloS one.

Reply to: "NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis": Cryptogenic cirrhosis should not be equated with NASH cirrhosis based on UNOS data mining and Bayesian 'doctrine of chances'.

S. Kantsevoy, P. Thuluvath, A. Thuluvath, 2018, Journal of hepatology.

Karnofsky Performance Status Following Liver Transplantation in Patients With Multiple Organ Failures and Probable Acute-on-Chronic Liver Failure.

P. Thuluvath, Talan Zhang, A. Thuluvath, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver transplantation in patients with multiple organ failures: Feasibility and outcomes.

P. Thuluvath, S. Hanish, A. Thuluvath, 2018, Journal of hepatology.

A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2017, Hepatology.

Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

M. Choti, I. Kamel, J. Geschwind, 2007, World journal of gastroenterology.

Cholangiocarcinoma: a review.

P. Thuluvath, C. Yeo, R. Rai, 1997, The Gastroenterologist.

Perioperative and Postoperative Use of Immunosuppressive Agents in Liver Transplantation

P. Thuluvath, K. Krok, 2006, International anesthesiology clinics.

Insurance Status but Not Race/Ethnicity are Associated with Outcomes in a Large Hospitalized Cohort of Patients with Cirrhosis.

K. Reddy, P. Kamath, P. Thuluvath, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hyponatremia in cirrhosis: pathophysiology and management.

P. Thuluvath, S. John, 2015, World journal of gastroenterology.

Survival Outcomes Are Not Affected When Liver Transplant Surgery Is Done at Night, During Weekends, or Summer Months

P. Thuluvath, Waseem Amjad, J. LaMattina, 2019, Transplantation direct.

A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis

H. Yoo, Anurag Maheshwari, P. Thuluvath, 2020, Digestive Diseases and Sciences.

Poor Survival After Retransplantation in NASH Cirrhosis

S. Kantsevoy, P. Thuluvath, Po-Hung Chen, 2019, Transplantation.

Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience

K. Reddy, P. Kamath, P. Thuluvath, 2020, Digestive Diseases and Sciences.

NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2018, Hepatology.

Features of Recurrent Primary Sclerosing Cholangitis in Two Consecutive Liver Allografts After Liver Transplantation

P. Thuluvath, R. Rai, A. Klein, 2001, Journal of clinical gastroenterology.

Cavoatrial shunt in the treatment of suprahepatic vena cava stricture after liver transplantation

P. Thuluvath, A. Tzakis, A. Klein, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute on Chronic Liver Failure and Death in Patients With Cirrhosis.

K. Reddy, P. Kamath, P. Thuluvath, 2020, Gastroenterology.

Acute liver failure in Budd–Chiari syndrome and a model to predict mortality

P. Thuluvath, Talan Zhang, Joseph Alukal, 2021, Hepatology International.

The Utility of TIPS in the Management of Budd-Chiari Syndrome

P. Thuluvath, D. Segev, R. Rai, 2005, Annals of surgery.

EUS-guided FNA could be another important tool for the early diagnosis of hepatocellular carcinoma.

P. Thuluvath, 2007, Gastrointestinal endoscopy.

Utility and Safety of EUS-guided Portal Vein FNA.

S. Kantsevoy, P. Thuluvath, 2011, Gastroenterology & hepatology.

Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease

P. Thuluvath, Talan Zhang, Mahak Chauhan, 2021, Digestive Diseases and Sciences.

Mental and physical health-related quality of life in patients with hepatitis C is related to baseline comorbidities and improves only marginally with hepatitis C cure

P. Thuluvath, Y. Savva, 2018, Clinical and Translational Gastroenterology.

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

Michael I. Jordan, Jasmine A. Berry, Mollie R. Cummins, 2023, JAMA.

How valid are our reference standards of nutrition?

P. Thuluvath, D. Triger, 1995, Nutrition.

A Nationwide Analysis of Budd-Chiari Syndrome in the United States.

P. Thuluvath, Talan Zhang, J. Alukal, 2020, Journal of clinical and experimental hepatology.

The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis

P. Kamath, P. Thuluvath, S. Biggins, 2018, The American Journal of Gastroenterology.

Ubi pus, ibi evacua: Optimal Non-surgical Gallbladder Drainage Following Acute Cholecystitis

P. Thuluvath, Amol Agarwal, 2020, Digestive Diseases and Sciences.

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial.

J. Cofer, P. Thuluvath, T. Pruett, 1996, Gastroenterology.

Are Gastrointestinal Symptoms Specific for COVID-19 Infection? A Prospective Case-Control Study from the United States

P. Thuluvath, Alan Chen, Zhang, 2020 .

Effectiveness of Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium difficile Infection: Community Hospital Experience: Presidential Poster: 592

S. Kantsevoy, S. Jagannath, Anurag Maheshwari, 2013 .

Sirolimus Monotherapy Versus Sirolimus in Combination with Steroids and/or MMF for Immunosuppression After Liver Transplantation

M. Torbenson, Anurag Maheshwari, P. Thuluvath, 2006, Digestive Diseases and Sciences.

Renal allograft survival in patients who had simultaneous liver and kidney transplantation compared with those who had renal transplantation alone.

P. Thuluvath, M. Krishnan, P. Scheel, 2001, Transplantation Proceedings.

Reply:

P. Thuluvath, G. Nguyen, 2008 .

EASL-CLIF criteria perform better than NACSELD to diagnose and prognosticate ACLF.

P. Thuluvath, Feng Li, 2021, Journal of hepatology.

Use of HCV-Positive Livers in HCV-Negative Recipients.

P. Thuluvath, Talan Zhang, S. Satapathy, 2020, The American journal of gastroenterology.

Prolonged Waiting Times for Liver Transplantation in Obese Patients

P. Thuluvath, D. Segev, R. Montgomery, 2008, Annals of surgery.

Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multi-center Inpatient Cirrhosis Cohort.

K. Reddy, P. Kamath, P. Thuluvath, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Progression of Stage 2 and 3 Acute Kidney Injury in Patients with Decompensated Cirrhosis and Ascites.

K. Reddy, P. Kamath, P. Thuluvath, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A large randomized clinical trial is necessary to establish the role of camrelizumab in hepatocellular carcinoma

P. Thuluvath, Nishal Ravindran, 2020, Annals of translational medicine.

Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time?

P. Thuluvath, K. Krok, 2005, The American Journal of Gastroenterology.

Nitrofurantoin induced chronic liver disease.

P. Thuluvath, M. Mckendrick, 1986, Journal of Antimicrobial Chemotherapy.

High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis

R. Marinho, J. Dufour, P. Thuluvath, 2017 .

The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation

H. Yoo, P. Thuluvath, 2002, Transplantation.

Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure

P. Thuluvath, Feng Li, 2022, World journal of hepatology.

EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF

P. Thuluvath, Feng Li, 2021, Journal of Hepatology.

Socioeconomic status does not affect the outcome of liver transplantation

David Edwin, H. Yoo, P. Thuluvath, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prognosis of hospitalized patients with cirrhosis and acute kidney disease

K. Reddy, P. Kamath, P. Thuluvath, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Acute on Chronic Liver Failure: Factors Associated With Transplantation

P. Thuluvath, S. Gray, R. Barth, 2021, Transplantation direct.

Reply to: "Type of organ failure and acute insult have important bearings in outcomes of liver transplantation: A pragmatic discourse".

P. Thuluvath, S. Hanish, A. Thuluvath, 2019, Journal of hepatology.

Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis Running head : Short-term mortality after discharge from hospital in cirrhosis

K. Reddy, P. Kamath, P. Thuluvath, 2016 .

The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation

H. Yoo, P. Thuluvath, E. Molmenti, 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Role of liver transplantation in the management of hepatocellular carcinoma.

P. Thuluvath, C. Patt, Cary H. Patt, 2002, Journal of vascular and interventional radiology : JVIR.

The village woman who winked and taught me the basics of medicine

P. Thuluvath, 2003, The Lancet.

Chronic active hepatitis in the type I polyglandular autoimmune syndrome.

P. Thuluvath, T. Michele, A. Sgrignoli, 1994, Postgraduate medical journal.

Asian Pacific Association for Study of the Liver (APASL)

M. Alter, M. Hashizume, M. Manns, 2003 .

The Cobas AmpliPrep – Cobas TaqMan Real-Time Polymerase Chain Reaction Assay Fails To Detect Hepatitis C Virus RNA in Highly Viremic Genotype 4 Clinical Samples To the

Anurag Maheshwari, P. Thuluvath, L. Verma, 2009 .

Off-Label Use of Multitarget Stool DNA Testing in Primary Care.

Anurag Maheshwari, P. Thuluvath, Talan Zhang, 2021, The American journal of gastroenterology.

A Randomized Controlled Trial of β-Blockers Versus Endoscopic Band Ligation for Primary Prophylaxis: A Large Sample Size is Required to Show a Difference in Bleeding Rates

S. Jagannath, Anurag Maheshwari, P. Thuluvath, 2005, Digestive Diseases and Sciences.

Liver biopsy in the real world—reporting, expert concordance and correlation with a pragmatic clinical diagnosis

M. Roden, P. Thuluvath, A. Sanyal, 2021, Alimentary pharmacology & therapeutics.

Short‐term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States

H. Yoo, P. Thuluvath, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Reply:

P. Thuluvath, 2004, American Journal of Gastroenterology.

Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.

P. Thuluvath, Waseem Amjad, C. To, 2020, The American journal of gastroenterology.

Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality.

P. Thuluvath, Talan Zhang, Mahak Chauhan, 2023, Annals of hepatology.

Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.

Hai Helen Li, Chuanwu Zhu, P. Hayes, 2023, The lancet. Gastroenterology & hepatology.

Evaluation of liver transplant recipients.

P. Thuluvath, 2011, Journal of clinical and experimental hepatology.

Outcome of liver transplantation in patients with diabetes mellitus: A case‐control study

P. Thuluvath, P. John, Preeti R John, 2001, Hepatology.

A Scoring Model to Predict In-Hospital Mortality in Patients With Budd–Chiari Syndrome

P. Thuluvath, Talan Zhang, J. Alukal, 2021, The American journal of gastroenterology.

Pleural effusions associated with pancreaticopleural fistula.

S. Williams, P. Thuluvath, D. Westaby, 1993, Thorax.

HUMAN MONOCYTIC EHRLICHIOSIS: AN EMERGING PATHOGEN IN TRANSPLANTATION

P. Thuluvath, W. Maley, A. Klein, 2001, Transplantation.

Acute hepatitis C

S. Ray, Anurag Maheshwari, P. Thuluvath, 2008, The Lancet.

Salmonella and complications related to age--Sheffield experience.

P. Thuluvath, M. Mckendrick, 1988, The Quarterly journal of medicine.

Disease proteomics

P. Thuluvath, H. Harsha, S. Kumari, 2009, Genomic Medicine.

Race is a predictor of in-hospital mortality after cholecystectomy, especially in those with portal hypertension.

P. Thuluvath, D. Segev, T. Laveist, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Accuracy and Inter-observer Agreement Among Endoscopists for Visual Identification of Colorectal Polyps Using Endoscopy Images

S. Kantsevoy, Anurag Maheshwari, P. Thuluvath, 2022, Digestive Diseases and Sciences.

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.

P. Thuluvath, U. Akarca, C. Hézode, 2015, Gastroenterology.

Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15

P. Thuluvath, R. Barth, J. LaMattina, 2020, Transplantation.

Reversal of NASH fibrosis with pharmacotherapy

P. Thuluvath, J. Alukal, 2019, Hepatology International.

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

P. Thuluvath, G. Everson, S. Pol, 2012, The Lancet. Infectious diseases.

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis.

R. Marinho, J. Dufour, P. Thuluvath, 2018, Journal of hepatology.